HumateP



Humate-P

Product Specs Humate-P
Manufacturer Name CSL Behring
Indications
  • Hemophilia A – Treatment and prevention of bleeding in adults.
  • Von Willebrand disease (VWD) – in adults and pediatric patients for: (1) Treatment of spontaneous and trauma-induced bleeding episodes, and (2) Prevention of excessive bleeding during and after surgery.

    • This applies to patients with severe VWD as well as patients with mild to moderate VWD where the use of desmospressin is known or suspected to be inadequate. Humate-P is not indicated for the prophylaxis of spontaneous bleeding episodes in VWD.

    Contraindications Anaphylactic or severe systemic reaction to antihemophilic factor or VWF preparations.
    Ratio of VWF: RCO to FVIII 2:4:1
    Viral Safety Process Cryoprecipitation, Al(OH)3 adsorption, glycine precipitation, and NaCl precipitation, heat treatment.
    Product Half-Life 8.4 to 17.4 hours
    Product Recovery Percentage 2.0 IU/dL rise per IU/kg
    Manufacturing Methods Plasma Derived
    Storage Requirements/Shelf Life
  • Stable for 36 months up to the expiration date when stored at temperatures up to 25°C (77°F).
  • Do not freeze.
  • Use within 3 hours of reconstitution.
    		•
    Nominal Vial Size & Diluent Volume 600 IU/5 mL
    1200 IU/10 mL
    2400 IU/15 mL


    Return to Manufacturer Name listing Return to Factor Type listing